VDR gene polymorphism | Patients N (%) | Control N* (%) | OR (95% CI)** | P–value*** |
---|---|---|---|---|
FokI | ||||
Co-dominant | N = 253 | N = 214 |  |  |
 FF | 45 (17.8) | 146 (68.2) | 1.00 (Reference)a |  |
 Ff | 30 (11.9) | 1 (0.5) | 97.3 (12.90–73.24) | < 0.0001 |
 ff | 178 (70.3) | 67 (31.3) | 8.62 (5.57–13.35) | < 0.0001 |
Dominant | ||||
 FF | 45 (17.8) | 146 (68.2) | 1.00 (Reference)a |  |
 Ff/ff (Ff + ff) | 208 (82.2) | 68 (31.8) | 9.92 (6.44–15.28) | < 0.0001 |
Alleles | N = 506 | N = 428 |  |  |
 F | 120 (23.7) | 293 (68.51) | 1.00 (Reference)a |  |
 f | 386 (76.3) | 135 (31.5) | 6.98 (5.23–9.3) | < 0.0001 |
TaqI | N = 253 | N = 214 |  |  |
Co-dominant | ||||
 TT | 96 (38) | 156 (73) | 1.00 (Reference)a |  |
 TC | 96 (38) | 36 (17) | 4.3 (2.73–6.86) | < 0.0001 |
 CC | 61 (24) | 22 (10) | 4.51 (2.60–7.81) | < 0.0001 |
Dominant | ||||
 TT | 96 (38) | 156 (73) | 1.00 (Reference)a |  |
 TC/CC (TC + CC) | 157 (76) | 58 (27) | 4.39 (2.96–6.52) | < 0.0001 |
Alleles | N = 506 | N = 428 |  |  |
 T | 288 (56.9) | 348 (81.3) | 1.00 (Reference)a |  |
 C | 218 (43.1) | 80 (18.9) | 3.29 (2.44–4.45) | < 0.0001 |